Stocks and Investing Stocks and Investing
Wed, January 4, 2023
Tue, January 3, 2023

Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Increased Target to $4.5 on, Jan 3rd, 2023


Published on 2024-10-28 00:43:14 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "ADMA Biologics, Inc." (ADMA) at Strong Buy with Increased Target from $4 to $4.5 on, Jan 3rd, 2023.

Raghuram has made no other calls on ADMA in the last 4 months.



There is 1 other peer that has a rating on ADMA. Out of the 1 peers that are also analyzing ADMA, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Anthony Petrone of "Mizuho" Maintained at Strong Buy with Increased Target to $6 on, Thursday, November 10th, 2022
Contributing Sources